MiMedx Group, Inc. Interest Income (Expense), Net
MiMedx Group, Inc. (MDXG) reported Interest Income (Expense), Net of -$1.69 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-04-30.
Discontinued › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNet · last filed 2024-04-30
- MiMedx Group, Inc. interest income (expense), net for the quarter ending 2024-03-31 was -$1.69M.
- MiMedx Group, Inc. interest income (expense), net for the quarter ending 2023-12-31 was -$1.59M.
- MiMedx Group, Inc. interest income (expense), net for the quarter ending 2023-09-30 was -$1.68M.
- MiMedx Group, Inc. interest income (expense), net for the quarter ending 2023-06-30 was -$1.63M.
- MiMedx Group, Inc. interest income (expense), net for fiscal 2023 was -$6.46M.
- MiMedx Group, Inc. interest income (expense), net for fiscal 2022 was -$5.02M.
- MiMedx Group, Inc. interest income (expense), net for fiscal 2021 was -$4.98M.
- MiMedx Group, Inc. interest income (expense), net for fiscal 2020 was -$7.94M.
| Period end | Interest Income (Expense), Net 3 month | Interest Income (Expense), Net 6 month | Interest Income (Expense), Net 9 month | Interest Income (Expense), Net 12 month |
|---|---|---|---|---|
| 2024-03-31 | -$1.69M 10-Q · filed 2024-04-30 | -$3.28M derived: sum of 2 quarters · filed 2024-04-30 | -$4.96M derived: sum of 3 quarters · filed 2024-04-30 | -$6.59M derived: sum of 4 quarters · filed 2024-04-30 |
| 2023-12-31 | -$1.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$3.27M derived: sum of 2 quarters · filed 2024-02-28 | -$4.90M derived: sum of 3 quarters · filed 2024-02-28 | -$6.46M 10-K · filed 2024-02-28 |
| 2023-09-30 | -$1.68M 10-Q · filed 2023-10-30 | -$3.31M derived: sum of 2 quarters · filed 2023-10-30 | -$4.86M 10-Q · filed 2023-10-30 | -$6.31M derived: sum of 4 quarters · filed 2024-04-30 |
| 2023-06-30 | -$1.63M 10-Q · filed 2023-08-01 | -$3.18M 10-Q · filed 2023-08-01 | -$4.63M derived: sum of 3 quarters · filed 2024-04-30 | -$5.90M derived: sum of 4 quarters · filed 2024-04-30 |
| 2023-03-31 | -$1.55M 10-Q · filed 2024-04-30 | -$3.00M derived: sum of 2 quarters · filed 2024-04-30 | -$4.27M derived: sum of 3 quarters · filed 2024-04-30 | -$5.44M derived: sum of 4 quarters · filed 2024-04-30 |
| 2022-12-31 | -$1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$2.72M derived: sum of 2 quarters · filed 2024-02-28 | -$3.89M derived: sum of 3 quarters · filed 2024-02-28 | -$5.02M 10-K · filed 2024-02-28 |
| 2022-09-30 | -$1.27M 10-Q · filed 2023-10-30 | -$2.44M derived: sum of 2 quarters · filed 2023-10-30 | -$3.57M 10-Q · filed 2023-10-30 | -$4.74M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$1.17M 10-Q · filed 2023-08-01 | -$2.29M 10-Q · filed 2023-08-01 | -$3.47M derived: sum of 3 quarters · filed 2024-02-28 | -$4.43M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$1.13M 10-Q · filed 2023-05-02 | -$2.30M derived: sum of 2 quarters · filed 2024-02-28 | -$3.26M derived: sum of 3 quarters · filed 2024-02-28 | -$4.63M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$1.17M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$2.14M derived: sum of 2 quarters · filed 2024-02-28 | -$3.51M derived: sum of 3 quarters · filed 2024-02-28 | -$4.98M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$963.00K 10-Q · filed 2022-11-02 | -$2.33M derived: sum of 2 quarters · filed 2022-11-02 | -$3.81M 10-Q · filed 2022-11-02 | -$5.31M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$1.37M 10-Q · filed 2022-08-02 | -$2.84M 10-Q · filed 2022-08-02 | -$4.35M derived: sum of 3 quarters · filed 2023-02-28 | -$5.82M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$1.47M 10-Q · filed 2022-05-03 | -$2.98M derived: sum of 2 quarters · filed 2023-02-28 | -$4.45M derived: sum of 3 quarters · filed 2023-02-28 | -$7.03M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$2.98M derived: sum of 2 quarters · filed 2023-02-28 | -$5.55M derived: sum of 3 quarters · filed 2023-02-28 | -$7.94M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$1.47M 10-Q · filed 2021-11-02 | -$4.05M derived: sum of 2 quarters · filed 2021-11-02 | -$6.43M 10-Q · filed 2021-11-02 | -$8.83M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$2.57M 10-Q · filed 2021-08-03 | -$4.96M 10-Q · filed 2021-08-03 | -$7.36M derived: sum of 3 quarters · filed 2022-02-28 | -$9.61M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$2.39M 10-Q · filed 2021-04-28 | -$4.78M derived: sum of 2 quarters · filed 2022-02-28 | -$7.04M derived: sum of 3 quarters · filed 2022-02-28 | -$7.31M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$2.40M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$4.65M derived: sum of 2 quarters · filed 2022-02-28 | -$4.92M derived: sum of 3 quarters · filed 2022-02-28 | -$4.71M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$2.25M 10-Q · filed 2020-11-04 | -$2.52M derived: sum of 2 quarters · filed 2020-11-04 | -$2.31M 10-Q · filed 2020-11-04 | |
| 2019-06-30 | -$269.00K 10-Q · filed 2020-08-04 | -$58.00K 10-Q · filed 2020-08-04 | ||
| 2019-03-31 | $211.00K 10-Q · filed 2020-07-06 | |||
| 2018-12-31 | $527.00K 10-K · filed 2021-03-08 | |||
| 2018-06-30 | $116.00K 10-Q · filed 2020-07-06 | $212.00K 10-Q · filed 2020-07-06 | ||
| 2018-03-31 | $96.00K 10-Q · filed 2020-07-06 | |||
| 2017-12-31 | -$87.00K 10-K · filed 2020-07-06 | |||
| 2016-12-31 | -$339.00K 10-K · filed 2020-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B |